文献速递头颈部肿瘤放疗放疗物理与技术

基于剂量组学的头颈部癌症放疗患者味觉障碍预测

Dosiomic-based prediction of dysgeusia in head & neck cancer patients treated with radiotherapy.
PubMed 文献 · Radiother Oncol · 2023-09-01

研究纳入80例接受根治或辅助放疗且随访至少24个月的头颈部癌症患者,在计划CT上勾画全舌并映射剂量图,从舌的6个区域提取145个剂量组学特征,用逻辑回归模型预测随访时味觉障碍分级,并与基于平均剂量的模型比较。剂量组学与平均剂量模型对急性味觉障碍预测均表现良好,AUC最高达0.88;对慢性味觉障碍预测,所有模型性能随时间下降,但剂量组学模型表现更优。作者结论认为剂量组学分析可识别预测急性味觉障碍的特征,且在慢性味觉障碍预测上优于传统平均剂量模型,但需更大规模前瞻性研究支持。

要点

  • 剂量组学与平均剂量模型对急性味觉障碍预测均表现良好,AUC最高达0.88。
  • 舌中央及前2/3区域对剂量组学模型预测最具预测性。
  • 慢性味觉障碍预测中所有模型性能随时间下降,剂量组学模型表现更优。

核心结论

  • 舌剂量组学分析识别出能够预测急性味觉障碍的特征。
  • 在慢性味觉障碍预测方面,剂量组学优于传统基于平均剂量的模型。
  • 在将剂量组学整合进放疗计划前,需更大规模的前瞻性研究支持这些结果。

研究设计与样本

  • 纳入80例接受根治或辅助放疗且随访至少24个月的头颈部癌症患者。
  • 收集治疗信息以及烟草和酒精消费情况。
  • 在计划CT上手动勾画全舌并映射至治疗计划系统获取的剂量图。
  • 对每例患者的舌6个区域分别提取145个剂量组学特征,输入逻辑回归模型预测随访时味觉障碍分级,并比较纳入与不纳入临床特征的情况。
  • 以基于平均剂量的模型作为参考。

主要发现

  • 剂量组学与平均剂量模型对急性味觉障碍预测均表现良好,AUC最高达0.88。
  • 剂量组学模型中,舌中央及前2/3区域最具预测性。
  • 所有模型对慢性味觉障碍预测的性能随时间逐渐下降,剂量组学模型数值更高。
  • 纳入吸烟和饮酒习惯未改善模型性能。

局限性

  • 在将剂量组学整合进放疗计划前,需更大规模的前瞻性研究支持这些结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the potential of dosiomics in predicting radiotherapy-induced taste distortion (dysgeusia) in head & neck (H&N) cancer. METHODS: A cohort of 80 H&N cancer patients treated with radical or adjuvant radiotherapy and with a follow-up of at least 24 months was enrolled. Treatment information, as well as tobacco and alcohol consumption were also collected. The whole tongue was manually delineated on the planning CT and mapped to the dose map retrieved from the treatment planning system. For every patient, 6 regions of the tongue were examined; for each of them, 145 dosiomic features were extracted from the dose map and fed to a logistic regression model to predict the grade of dysgeusia at follow-up, with and without including clinical features. A mean dose-based model was considered for reference. RESULTS: Both dosiomics and mean dose models achieved good prediction performance for acute dysgeusia with AUC up to 0.88. For the dosiomic model, the central and anterior ⅔ regions of the tongue were the most predictive. For all models, a gradual reduction in the performance was observed at later times for chronic dysgeusia prediction, with higher values for dosiomics. The inclusion of smoke and alcohol habits did not improve model performances. CONCLUSION: The dosiomic analysis of the dose to the tongue identified features able to predict acute dysgeusia. Dosiomics resulted superior to the conventional mean dose-based model for chronic dysgeusia prediction. Larger, prospective studies are needed to support these results before integrating dosiomics in radiotherapy planning.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Busato F, Fiorentin D, Bettinelli A, et al. Dosiomic-based prediction of dysgeusia in head & neck cancer patients treated with radiotherapy. Radiother Oncol. 2023. PMID: 37660751. doi:10.1016/j.radonc.2023.109896

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。